VIM and head and neck cancer: Indeed, using recombinant human IL-8 as a treatment of head and neck cancer cells, their Western blot analyses revealed a decrease in the expression of E-cadherin and an increase in the expression of MMP2, MMP9, and vimentin compared to the untreated conditions.